171 related articles for article (PubMed ID: 38240571)
1. Hepatitis B virus evades the immune system by suppressing the NF-κB signaling pathway with DENND2A.
Ide M; Tabata N; Yonemura Y; Murai K; Wang Y; Ishida A; Honda M; Kaneko S; Ito S; Yanagawa H
Microbiol Spectr; 2024 Mar; 12(3):e0378523. PubMed ID: 38240571
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
[TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotide exchange factor DOCK11-binding peptide fused with a single chain antibody inhibits hepatitis B virus infection and replication.
Ide M; Tabata N; Yonemura Y; Shirasaki T; Murai K; Wang Y; Ishida A; Okada H; Honda M; Kaneko S; Doi N; Ito S; Yanagawa H
J Biol Chem; 2022 Jul; 298(7):102097. PubMed ID: 35660020
[TBL] [Abstract][Full Text] [Related]
4. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
5. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.
Hösel M; Quasdorff M; Wiegmann K; Webb D; Zedler U; Broxtermann M; Tedjokusumo R; Esser K; Arzberger S; Kirschning CJ; Langenkamp A; Falk C; Büning H; Rose-John S; Protzer U
Hepatology; 2009 Dec; 50(6):1773-82. PubMed ID: 19937696
[TBL] [Abstract][Full Text] [Related]
6. Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection.
Luo X; Zhang R; Lu M; Liu S; Baba HA; Gerken G; Wedemeyer H; Broering R
Front Immunol; 2021; 12():684424. PubMed ID: 34113355
[TBL] [Abstract][Full Text] [Related]
7. DOCK11 and DENND2A play pivotal roles in the maintenance of hepatitis B virus in host cells.
Hashimoto S; Shirasaki T; Yamashita T; Iwabuchi S; Suzuki Y; Takamura Y; Ukita Y; Deshimaru S; Okayama T; Ikeo K; Kuroki K; Kawaguchi K; Mizukoshi E; Matsushima K; Honda M; Kaneko S
PLoS One; 2021; 16(2):e0246313. PubMed ID: 33539396
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus polymerase suppresses NF-κB signaling by inhibiting the activity of IKKs via interaction with Hsp90β.
Liu D; Wu A; Cui L; Hao R; Wang Y; He J; Guo D
PLoS One; 2014; 9(3):e91658. PubMed ID: 24618592
[TBL] [Abstract][Full Text] [Related]
9. Interplay Between Non-Canonical NF-κB Signaling and Hepatitis B Virus Infection.
Lu X; Chen Q; Liu H; Zhang X
Front Immunol; 2021; 12():730684. PubMed ID: 34659217
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial HIGD1A inhibits hepatitis B virus transcription and replication through the cellular PNKD-NF-κB-NR2F1 nexus.
Xie Z; Shen S; Huang K; Wang W; Liu Z; Zhang H; Lu M; Sun J; Hou J; Liu H; Guo H; Zhang X
J Med Virol; 2023 Apr; 95(4):e28749. PubMed ID: 37185850
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
13. Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways.
Liu S; Peng N; Xie J; Hao Q; Zhang M; Zhang Y; Xia Z; Xu G; Zhao F; Wang Q; Han T; Zhu Y
J Hepatol; 2015 May; 62(5):1015-23. PubMed ID: 25481566
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages.
Cheng X; Xia Y; Serti E; Block PD; Chung M; Chayama K; Rehermann B; Liang TJ
Hepatology; 2017 Dec; 66(6):1779-1793. PubMed ID: 28665004
[TBL] [Abstract][Full Text] [Related]
15. MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter.
Ibrahim MK; Abdelhafez TH; Takeuchi JS; Wakae K; Sugiyama M; Tsuge M; Ito M; Watashi K; El Kassas M; Kato T; Murayama A; Suzuki T; Chayama K; Shimotohno K; Muramatsu M; Aly HH; Wakita T
J Virol; 2021 Jul; 95(15):e0076721. PubMed ID: 33980595
[TBL] [Abstract][Full Text] [Related]
16. TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity.
Tian X; Dong H; Lai X; Ou G; Cao J; Shi J; Xiang C; Wang L; Zhang X; Zhang K; Song J; Deng J; Deng H; Lu S; Zhuang H; Li T; Xiang K
Antiviral Res; 2022 Nov; 207():105406. PubMed ID: 36084850
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway
Deng F; Xu G; Cheng Z; Huang Y; Ma C; Luo C; Yu C; Wang J; Xu X; Liu S; Zhu Y
Front Immunol; 2021; 12():618196. PubMed ID: 33717111
[TBL] [Abstract][Full Text] [Related]
18. ATP1B3 cooperates with BST-2 to promote hepatitis B virus restriction.
Zheng B; Zhang J; Zheng T; Wang H; Li Z; Huan C; Ning S; Wang Y; Zhang W
J Med Virol; 2020 Feb; 92(2):201-209. PubMed ID: 31556466
[TBL] [Abstract][Full Text] [Related]
19. DNA-dependent activator of interferon-regulatory factors inhibits hepatitis B virus replication.
Chen QY; Liu YH; Li JH; Wang ZK; Liu JX; Yuan ZH
World J Gastroenterol; 2012 Jun; 18(22):2850-8. PubMed ID: 22719196
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.
Biermer M; Puro R; Schneider RJ
J Virol; 2003 Apr; 77(7):4033-42. PubMed ID: 12634363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
